Clinical Trial Summary Result Information

Clinical trial summary result Information from completed trials in the English-language are available below and on TakedaClinicalTrials.com

If you are a patient, physician, or researcher seeking more information about Takeda's completed clinical trials in the Japanese language please click here.


Search

TMX-67_204

A Multicenter, Randomized, Double-Blind, Phase 2 Study to Evaluate the Effect of Febuxostat Versus Placebo in Joint Damage in Hyperuricemic Subjects With Early Gout
www.clinicaltrials.gov/ct2/show/results/NCT01078389

TAK-390MR_206

A Phase 2 Open-Label, Multicenter, 4-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Relief of Heartburn, in Adolescent S...
www.clinicaltrials.gov/ct2/show/results/NCT01642602

C13013

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Single Dose Study in Healthy Subjects to Determine the Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedoliz...
www.clinicaltrials.gov/ct2/show/NCT01981616

C13011

A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
www.clinicaltrials.gov/ct2/show/NCT01224171

C13007

A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients With Moderate to Severe C...
www.clinicaltrials.gov/ct2/show/NCT00783692

C13004

Phase 2, Multiple Dose, Open-Label Study to Determine the Long Term Safety of MLN0002 in Patients With Ulcerative Colitis and Crohn's Disease
www.clinicaltrials.gov/ct2/show/NCT00619489

C13006

A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients With Moderate to Severe Ulcerative Coli...
www.clinicaltrials.gov/ct2/show/NCT00783718

FP-002-IM

Adherence to PTH(1-84) Treatment in Europe. A Non-interventional Cohort Study Collecting Safety Information and Examining Reasons and Predictors for Adherence to PTH(1-84) Treatment in Usual Clinical ...
www.clinicaltrials.gov/ct2/show/results/NCT00478569